Trial Profile
Ferric carboxymaltose the for treatment of anaemia in patients with lymphoid malignancies, chemotherapy-induced anaemia and functional iron deficiency
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2014
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Chemotherapy-induced anaemia; Iron deficiency anaemia
- Focus Therapeutic Use
- 24 Apr 2014 New trial record